RLAY (STOCKS)
Relay Therapeutics, Inc. Common Stock
$19.930000
-0.140000 (-0.70%)
Prev close: $20.070000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sanjiv K. Patel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,669.84M
- Employees
- 197
- P/E (TTM)
- -12.81
- P/B (TTM)
- 4.93
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
12
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.41 | $-0.40 | -0.0111 | -2.78% |
|
Mar 2026 (Q1)
|
$-0.41 | $-0.38 | -0.0256 | -6.66% |
|
Dec 2025 (Q4)
|
$-0.32 | $-0.41 | +0.0924 | +22.41% |
|
Sep 2025 (Q3)
|
$-0.43 | $-0.42 | -0.0062 | -1.46% |
Financial Statements
| Revenues | $10.35M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $320.79M |
| Operating Expenses | $320.79M |
| Operating Income/Loss | -$310.44M |
| Income/Loss From Continuing Operations After Tax | -$286.04M |
| Income/Loss From Continuing Operations Before Tax | -$63.80M |
| Net Income/Loss | -$286.04M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$286.04M |
| Net Income/Loss Available To Common Stockholders, Basic | -$286.04M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.56 |
| Diluted Earnings Per Share | -$1.56 |
| Basic Average Shares | 555,700,481 |
| Assets | $967.46M |
| Current Assets | $928.08M |
| Prepaid Expenses | $8.74M |
| Other Current Assets | $919.35M |
| Noncurrent Assets | $39.38M |
| Fixed Assets | $862.00K |
| Other Non-current Assets | $38.51M |
| Liabilities | $77.45M |
| Current Liabilities | $50.80M |
| Accounts Payable | $11.46M |
| Other Current Liabilities | $39.35M |
| Noncurrent Liabilities | $26.64M |
| Equity | $890.01M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $890.01M |
| Liabilities And Equity | $967.46M |
| Net Cash Flow From Operating Activities | -$212.21M |
| Net Cash Flow From Operating Activities, Continuing | -$212.21M |
| Net Cash Flow From Investing Activities | -$244.94M |
| Net Cash Flow From Investing Activities, Continuing | -$244.94M |
| Net Cash Flow From Financing Activities | $463.47M |
| Net Cash Flow From Financing Activities, Continuing | $463.47M |
| Net Cash Flow | $6.33M |
| Net Cash Flow, Continuing | $6.33M |
| Comprehensive Income/Loss | -$287.43M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$287.43M |
| Other Comprehensive Income/Loss | -$1.39M |